Free Access
| Issue |
Med Sci (Paris)
Volume 23, Number 4, Avril 2007
|
|
|---|---|---|
| Page(s) | 356 - 358 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2007234356 | |
| Published online | 15 April 2007 | |
- Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002; 2 : 103–12. [Google Scholar]
- Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002; 2 : 910–7. [Google Scholar]
- Dyer MA, Rodriguez-Galindo C, Wilson MW. Use of preclinical models to improve treatment of retinoblastoma. PLoS Med 2005; 2 : e332. [Google Scholar]
- Laurie NA, Donovan SL, Shih CS, et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444 : 61–6. [Google Scholar]
- Laurie NA, Gray JK, Zhang J, et al. Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res 2005; 11 : 7569–78. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.